Introducing Parthenon: Transforming Healthcare with AI-Powered Outcomes Research
Pinned Post | Originally published March 7, 2026
Outcomes research has evolved alongside the broader arc of healthcare analytics infrastructure. Early siloed clinical systems produced fragmented administrative and claims data with limited analytic utility — adequate for billing, but structurally unsuitable for longitudinal cohort construction or comparative effectiveness work. The meaningful use era expanded the availability of structured clinical data, yet interoperability failures meant that patient journeys remained fractured across institutional boundaries, undermining the real-world evidence studies that outcomes researchers depend on. The shift to integrated analytics platforms — particularly the adoption of common data models like OMOP/OHDSI — marked a genuine inflection point: federated network studies, standardized phenotyping, and reproducible retrospective analyses became operationally feasible at scale. Now a fourth generation is taking shape, one in which AI-augmented clinical intelligence moves outcomes research from retrospective description toward prospective, near-real-time evidence generation — enabling dynamic cohort surveillance, treatment heterogeneity detection, and value-based care signal identification that was previously impractical outside of narrow clinical trial settings.
Parthenon is built for this fourth generation.
Why We Built This
The problems with traditional healthcare analytics infrastructure are well-documented but stubbornly persistent. Data fragmentation scatters patient information across EHR, laboratory, radiology, and claims platforms with inconsistent terminologies. Analytics teams are overwhelmed with routine reporting demands, leaving limited capacity for the strategic analysis that actually improves outcomes. And the insights that do emerge are retrospective — care gaps identified too late for optimal impact, interventions that are reactive rather than proactive.
The OHDSI community addressed part of this problem brilliantly. The OMOP Common Data Model standardizes clinical data across institutions. HADES packages encode decades of pharmacoepidemiology methodology. Atlas provides a visual interface for cohort building and analysis design. But the toolchain has grown to 15+ disconnected applications — Atlas, WebAPI, Achilles, DQD, CohortGenerator, CohortMethod, PatientLevelPrediction, and more — each with its own deployment, its own UI paradigm, and its own learning curve.
Parthenon replaces all of them with a single application.
What Parthenon Does
At its core, Parthenon is a unified outcomes research platform built on OMOP CDM v5.4. A researcher can move through the entire real-world evidence lifecycle without leaving the browser: explore vocabularies and build concept sets, construct patient cohorts with a visual builder, then run characterization, incidence rates, treatment pathways, population-level estimation, patient-level prediction, self-controlled case series, and evidence synthesis.
But Parthenon extends well beyond what Atlas ever offered.
Genomics — Upload VCF files, annotate variants against ClinVar, browse mutations in an interactive variant browser, and convene virtual tumor boards with AI-assisted interpretation. This bridges the gap between population-level observational research and precision medicine.
Medical Imaging — View DICOM studies with a built-in Cornerstone3D viewer, connect to PACS systems via WADO-RS, and incorporate imaging criteria directly into cohort definitions. Radiogenomics analysis becomes possible within the same platform where you run your epidemiological studies.
Health Economics & Outcomes Research — Model cost-effectiveness, identify care gaps across populations, and run economic analytics. The care gap module tracks screening compliance, flags missed interventions, and quantifies the financial impact of closing gaps at various capture rates.
FHIR R4 Integration — Connect to EHR systems using SMART Backend Services for automated bulk export and incremental sync. Clinical data flows from production EHR systems into your OMOP CDM without manual ETL intervention.
AI-Assisted Analysis — An integrated AI service powered by Ollama and MedGemma provides semantic concept search, natural-language cohort suggestions, clinical result interpretation, and genomic variant summarization. The AI doesn't replace the researcher — it reduces the time between question and insight.
The Architecture
Parthenon is a containerized multi-service application orchestrated with Docker Compose. The frontend is React 19 with TypeScript strict mode, Tailwind CSS, and Zustand for state management. The backend is Laravel 11 with PHP 8.4, using Sanctum authentication and Spatie role-based access control. A Python FastAPI service handles AI capabilities — MedGemma through Ollama, pgvector embeddings for semantic search. An R Plumber API executes HADES analyses — CohortMethod, PatientLevelPrediction, SelfControlledCaseSeries — against the CDM. PostgreSQL 16 stores both application data and the OMOP CDM across multiple schemas. Redis powers the job queue via Laravel Horizon. Solr provides full-text vocabulary search.
Eight Docker services, one docker compose up -d command. A Python installer walks you through configuration in nine phases — from preflight checks through admin account creation — with optional Eunomia demo data so you can start exploring immediately.
The AI Imperative
The PDF that inspired this platform — Transforming Healthcare Delivery: Next-Generation Clinical Analytics Powered by Artificial Intelligence — makes the business case quantitatively. Six in ten Americans live with chronic disease, driving $4.1 trillion in annual healthcare costs. Traditional monitoring of conditions like CKD achieves just 3% compliance across all seven recommended measures. AI-enhanced approaches have demonstrated 267% improvement in compliance, prevention of 15-20 dialysis cases per year, and $3-4 million in annual cost savings per 10,000 patients.
These aren't theoretical projections. They're the measurable outcomes that become possible when you combine standardized clinical data (OMOP CDM), validated analytical methods (HADES), and machine learning that identifies patterns humans can't see at scale.
Parthenon's care gap module, population risk scoring, and predictive analytics are designed to deliver exactly this kind of impact — clinical decision support that anticipates patient needs rather than simply responding to events.
Building in Public
This blog will serve as a daily development journal. Every day, we'll document what was built, what broke, what we learned, and what's next. The first technical post — about the five bugs we had to fix before HADES analyses would run in production — is already live. It's the kind of hard-won knowledge that doesn't appear in any documentation, and we think sharing it openly makes the entire OHDSI ecosystem stronger.
We're also automating this process. A Claude Code agent reviews the day's git history every night and generates a narrative dev log post — not just a commit list, but a story about what the code changes mean and why they matter.
What's Next
The platform's roadmap follows a four-phase journey. The foundation phase establishes data integration and baseline analytics. Core analytics introduces care bundles for high-impact conditions. Advanced capabilities bring full population health management with HCC coding optimization and clinical decision support integration. The transformation phase enables value-based care analytics, precision medicine, and continuously learning systems.
We're deep in the foundation and core analytics phases right now, shipping features daily. Follow this blog to watch it happen.
Parthenon is open-source and available at github.com/sudoshi/Parthenon. Built by Acumenus Data Sciences.